Dendrimeric nanosystem consistently circumvents heterogeneous drug response and resistance in pancreatic cancer

Pancreatic ductal adenocarcinoma (PDAC) is a deadly cancer with no efficacious treatment. The application of nanomedicine is expected to bring new hope to PDAC treatment. In this study, we report a novel supramolecular dendrimeric nanosystem carrying the anticancer drug doxorubicin, which demonstrat...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Juan, Chen, Chao, Wei, Tuo, Gayet, Odile, Loncle, Céline, Borge, Laurence, Dusetti, Nelson, Ma, Xiaowei, Marson, Domenico, Laurini, Erik, Pricl, Sabrina, Gu, Zhongwei, Iovanna, Juan, Peng, Ling, Liang, Xing‐Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10291567/
https://www.ncbi.nlm.nih.gov/pubmed/37366462
http://dx.doi.org/10.1002/EXP.20210003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10291567/
https://www.ncbi.nlm.nih.gov/pubmed/37366462
http://dx.doi.org/10.1002/EXP.20210003

Ejemplares similares